Are you striving to improve the cost-efficiency and accuracy of your lab's drug abuse testing? Wondering how enzyme performance could directly affect column life and test reliability? Curious about what sets a high-quality β-glucuronidase like IMCSzyme RT apart? Then, this on-demand webinar is a must-watch.

Join speaker Amanda McGee as she provides a comprehensive overview of the vital balance between enzyme performance and column deterioration. Amanda presents a detailed study exploring the effects of various amounts of β-glucuronidase protein on drug analyte recoveries and column longevity. This study challenges enzyme performance in patient samples using a range of enzyme amounts in pooled, problematic urine samples. Using too little enzyme will result in low analyte recoveries and potential false negatives, while using too much enzyme without the proper sample preparation will result in column deterioration and poor peak shape quality.

By investing your time in this webinar, you'll gain valuable insights into how the optimal enzyme concentration not only guarantees high-quality peak shapes and accurate test results but also helps prevent expensive reruns, column replacements, and machine downtime. Discover why choosing high-quality enzymes like IMCSzyme RT is a strategic investment that delivers superior performance and significant cost savings. Access this essential resource at your leisure and share it with your colleagues to take your lab's drugs of abuse testing to the next level.

At the end of this eye-opening webinar, you will:

• Understand the effects of different concentrations of β-glucuronidases on glucuronidated compounds' hydrolysis and the subsequent impact on analyte detection.
• Learn about the relationship between enzyme usage and LC column life, focusing on how to avoid deterioration and poor peak shape quality.
• Gain insights into strategies to balance enzyme performance with the need for accurate and reliable drug testing results, minimizing potential false negatives.